Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity

Mounting evidence suggests that immunotherapies are a promising new class of anticancer therapies. However, the immunosuppressive tumor microenvironment (TME), poor immunogenicity, and off-target toxicity hinder the broader implementation of immunotherapies. Here, we describe a novel strategy combin...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Jingjing, Wang, Huifang, Ding, Wenxiu, Huang, Jianxiang, Zhou, Xuefei, Wang, Huiyang, Dong, Xue, Li, Guangyao, Chen, Enguo, Zhou, Fei, Fan, Hongjie, Xia, Jingya, Shen, Bo, Cai, Da, Lan, Pengxun, Jiang, Hanliang, Ling, Jun, Cheng, Zhen, Liu, Xiangrui, Sun, Jihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455183/
https://www.ncbi.nlm.nih.gov/pubmed/32923651
http://dx.doi.org/10.1126/sciadv.abc3646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455183/
https://www.ncbi.nlm.nih.gov/pubmed/32923651
http://dx.doi.org/10.1126/sciadv.abc3646

Ejemplares similares